Patients with a triple-negative breast cancer (TNBC; progesterone receptor negative, oestrogen receptor negative, HER-2-neu receptor negative) who died during the follow-up period, expressed drastically higher levels of IL-15 as opposed to decreased IL-15 levels in patients who remained alive and showed a positive OS and DFS. Here, IL15 is linked to triple-negative breast carcinoma.